News > Trial to study efficacy of BCG vaccine against COVID-19
Trial to study efficacy of BCG vaccine against COVID-19
The Hindu | 01/09/2020 08:42 AM | Click to read full article
JSSAHER in Mysuru will soon begin trials to study the efficacy of BCG, the anti-tuberculosis vaccine, in providing a protective cover against COVID-19.
Though the BCG vaccine is mandatorily given to children in India, immunity is believed to wane with time and reduce substantially after 60 years. The vaccine will be a “booster dose” to see if it can provide additional cover to tuberculosis and also cover COVID-19 in the process.